Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma - Wikidata - awgldk - TriplyDB

Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma

Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma

http://www.wikidata.org/entity/Q36145632

about

Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy Asn-Gly-Arg-modified polydopamine-coated nanoparticles for dual-targeting therapy of brain glioma in rats.Crossing the barrier: treatment of brain tumors using nanochain particles.Use of single chain antibody derivatives for targeted drug delivery.Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma.Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433).Targeting Malignant Brain Tumors with Antibodies.Targeting transferrin receptor delivery of temozolomide for a potential glioma stem cell-mediated therapy.Solid Lipid Nanoparticles Carrying Temozolomide for Melanoma Treatment. Preliminary In Vitro and In Vivo Studies.Tunable Stability of Imidazotetrazines Leads to a Potent Compound for Glioblastoma Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma Nanotechnology for treatment of glioblastoma multiforme Constitutional mismatch repair-deficiency: current problems and emerging therapeutic strategies

P2860

Q26745710-75AC76E8-8DDB-4DC0-8C02-125905FF78AA Q37687455-35A9A426-1DD3-444A-B00A-3EBB7D3236D2 Q38691508-839B564F-7AFD-498D-9554-1948654CF444 Q38850046-3942B622-085D-4710-AB04-B16830125F78 Q38998571-3BFB98FC-6306-4CA6-94C1-F56B577CE0DC Q41141280-2A2B5332-3EC4-46A3-8FDA-C18189F53B03 Q42267793-60C54F89-2F79-4624-BA8E-4293058C1898 Q47105795-4D2D685B-4E00-4F6C-B069-10D2E45811F7 Q48175785-D8916722-22E4-4F50-8BA2-3C09CC44139A Q57180130-DEF926ED-0FBF-4BF7-A82A-4E90C6E99EE4 Q57814961-C1B78AFD-F255-4021-88B5-916A6CC79F33 Q58695662-BE896320-EE8A-4195-8BFF-64C632EEF2C1 Q59128454-CD88CB76-8C3E-4709-B2E0-3E953C24C97F

P2860

Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma

http://www.wikidata.org/entity/Q36145632

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Encapsulation of temozolomide ...... a mouse model of glioblastoma

@ast

Encapsulation of temozolomide ...... a mouse model of glioblastoma

@en

type

label

Encapsulation of temozolomide ...... a mouse model of glioblastoma

@ast

Encapsulation of temozolomide ...... a mouse model of glioblastoma

@en

prefLabel

Encapsulation of temozolomide ...... a mouse model of glioblastoma

@ast

Encapsulation of temozolomide ...... a mouse model of glioblastoma

@en

P1433

Q36145632-577DCD50-4AEE-4A30-B2AE-5491FDBB0BF9

P1476

Q36145632-AD843ADF-306E-4B69-A26E-BB07CA18A119

P2093

Q36145632-208A2849-01A4-4C47-B15C-776CBDDE9D23

Q36145632-2B40EC9C-1253-485F-8125-E2890705867F

Q36145632-9C9580DC-11CA-4467-82C7-427376D6F0B5

Q36145632-A37A3CB3-0F9E-4AD9-80B9-0C79B1FD6E1B

Q36145632-D811ACC5-155B-4BFA-9536-5160533CBF4C

Q36145632-E1AC6755-983F-4581-84CB-114D341C25BE

P2860

Q36145632-050F4917-2D18-477E-8B33-755523B81A00

Q36145632-06EC07C6-ED64-4D67-9F27-108514A2DA90

Q36145632-0DE5CCF3-4ED2-44A4-831D-DF8586055F53

Q36145632-12B566FE-9786-49D0-832B-35241251B574

Q36145632-14B0B7C2-20D2-4B5F-A2D6-A56BC01ABAA0

Q36145632-1AB25116-82C5-4774-9D93-D6110407A960

Q36145632-2563D214-731A-4EF7-98AF-06D9DCA0AE7D

Q36145632-26D30AA4-F345-4762-9F31-AADA8E8D9FD5

Q36145632-2991A7CD-209D-492F-90EA-1A021CF93929

Q36145632-30360E4A-92A3-4576-832E-6F6856F47CFC

P304

Q36145632-696226BA-B85D-407B-B1D9-09EFC6F0BFFA

P31

Q36145632-5D683D1D-1D87-4709-A122-20EAAA95CCC2

P356

Q36145632-77AA77F9-ACB7-47D6-8E6E-9B5D31CD6C2D

P407

Q36145632-9B1713DC-7A81-49E8-AC91-453B5EEB7CA9

P433

Q36145632-034266B4-A897-49C3-B544-F9E90B9B85FA

P478

Q36145632-DBE9E34E-BC25-4279-A9DC-AB58B17A0429

P577

Q36145632-66C669B6-CC4D-4DC7-94BF-E841A2A7C6C7

P5875

Q36145632-5AD2AE8D-D525-41FA-9559-E1134561C9CA

P698

Q36145632-D2C55208-12D6-4D71-AF10-124818E3BC81

P932

Q36145632-0E58E2FE-395F-42E1-9BA9-253A890170CB

P356

J.CANLET.2015.08.022

P1433

P1476

Encapsulation of temozolomide ...... a mouse model of glioblastoma

@en

P2093

Antonina Rait

http://www.w3.org/2001/XMLSchema#string

Eric Kim

http://www.w3.org/2001/XMLSchema#string

Esther H Chang

http://www.w3.org/2001/XMLSchema#string

James DeMarco

http://www.w3.org/2001/XMLSchema#string

Kathleen F Pirollo

http://www.w3.org/2001/XMLSchema#string

Sang-Soo Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier

The transferrin receptor part II: targeted delivery of therapeutic agents into cancer cells

Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv

A nanoparticle carrying the p53 gene targets tumors including cancer stem cells, sensitizes glioblastoma to chemotherapy and improves survival.

Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo

Extended-schedule dose-dense temozolomide in refractory gliomas

Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy.

Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1

A tumor-targeting p53 nanodelivery system limits chemoresistance to temozolomide prolonging survival in a mouse model of glioblastoma multiforme.

Chemoresistance of glioblastoma cancer stem cells--much more complex than expected.

P304

250-258

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CANLET.2015.08.022

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

369

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281349734

http://www.w3.org/2001/XMLSchema#string

P698

26325605

http://www.w3.org/2001/XMLSchema#string

P932

4600672

http://www.w3.org/2001/XMLSchema#string